144 completed, 47 terminated, 45 recruiting, 28 active not recruiting. 193 Phase 2, 104 Phase 1, 42 Phase 3, 22 Not applicable, 6 Early Phase 1.
Follow Stem Cell Transplantation: new trials by email Literature Review of Stem Cell Transplantation trials Research Report on Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma Allogeneic Hematopoietic Stem Cell Transplantation, Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Cyclophosphamide - Multiple Myeloma, Recurrent Multiple Myeloma | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2027-06-01 | 2026-09-11 | |
| Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 74 | 2027-04-20 | 2026-10-26 |
| Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy - Acute Myeloid Leukemia | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 244 | 2027-01-15 | 2026-10-20 |
| Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma 3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection - Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | National Cancer Institute (NCI) | 374 | 2026-12-04 | 2026-07-08 |
| CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation Hematopoietic Cell Transplantation, Cyclophosphamide, Tacrolimus - Graft -Versus-host-disease | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 72 | 2026-11-01 | 2026-09-08 |
| Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome Allogeneic Hematopoietic Stem Cell Transplantation, Arsenic Trioxide, Biospecimen Collection - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Not yet recruiting | University of Michigan Rogel Cancer Center | 20 | 2026-11-01 | 2026-07-30 |
| A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant Biospecimen Collection, Electronic Health Record Review, Haploidentical Hematopoietic Cell Transplantation - Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia | Phase 1 | Recruiting | City of Hope Medical Center | 46 | 2026-09-09 | 2026-10-23 |
| Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Biopsy Procedure, Biospecimen Collection - Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified | Phase 2 | Recruiting | City of Hope Medical Center | 43 | 2026-07-27 | 2026-08-28 |
| Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant Biospecimen Collection, Busulfan, Computed Tomography - Acute Myeloid Leukemia, Graft Versus Host Disease | Phase 1 | Recruiting | City of Hope Medical Center | 15 | 2026-06-12 | 2026-07-01 |
| Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial Allogeneic Hematopoietic Stem Cell Transplantation, Axatilimab, Biospecimen Collection - Hematopoietic and Lymphatic System Neoplasm | Phase 2 | Withdrawn | Mayo Clinic | 2026-06-01 | 2026-09-03 | |
| Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) Hematopoietic stem cell transplant (HSCT) - Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder | Phase 2 | Recruiting | Paul Szabolcs | 25 | 2026-05-04 | 2026-05-15 |
| Horizon Two: HR NDMM (MMRC-100) Bispecific Monoclonal Antibody and Triplet Therapy, Monoclonal Antibody with Stem Cell Transplant - High Risk Newly Diagnosed Multiple Myeloma | Phase 2 | Recruiting | Multiple Myeloma Research Consortium | 300 | 2026-04-30 | 2026-10-02 |
| Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia | Phase 1 | Recruiting | OHSU Knight Cancer Institute | 40 | 2026-04-21 | 2026-10-05 |
| Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation Venetoclax, Hematopoietic Cell Transplantation Conditioning Regimen, Kidney Transplant - Kidney Failure Chronic, Stem Cell Transplant | Early Phase 1 | Recruiting | Massachusetts General Hospital | 3 | 2026-02-04 | 2026-10-14 |
| Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes Ruxolitinib, Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan - Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 50 | 2026-02-04 | 2026-10-19 |
| Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Anti-CD19-CAR CMV-specific T-lymphocytes, Biospecimen Collection - Acute Lymphoblastic Leukemia | Early Phase 1 | Recruiting | City of Hope Medical Center | 15 | 2025-12-30 | 2026-04-27 |
| Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 20 | 2025-09-26 | 2026-07-20 |
| Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia, Acute Undifferentiated Leukemia | Phase 1 / Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 36 | 2025-09-23 | 2026-05-15 |
| Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cytarabine - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 2 | Recruiting | University of California, Davis | 25 | 2025-07-31 | 2026-06-30 |
| A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation Conditioning Regimen A, Conditioning Regimen B, Conditioning Regimen C - AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL) | Phase 2 | Recruiting | Center for International Blood and Marrow Transplant Research | 358 | 2025-07-25 | 2026-03-17 |
Showing 20 of 317. Sign in to see all of them.
Leukemia, Myeloid, Acute (65) · Myelodysplastic Syndromes (51) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (48) · Multiple Myeloma (38) · Lymphoma (37) · Leukemia (35) · Lymphoma, Non-Hodgkin (29) · Hodgkin Disease (24) · Leukemia, Lymphocytic, Chronic, B-Cell (24) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (22) · Hematologic Neoplasms (19) · Lymphoma, Large B-Cell, Diffuse (16) · Graft vs Host Disease (15) · Primary Myelofibrosis (15) · Leukemia, Myelomonocytic, Chronic (11)
M.D. Anderson Cancer Center (56) · Masonic Cancer Center, University of Minnesota (26) · City of Hope Medical Center (22) · National Cancer Institute (NCI) (18) · Fred Hutchinson Cancer Center (15) · St. Jude Children's Research Hospital (13) · Children's Oncology Group (10) · Royan Institute (9) · Washington University School of Medicine (8) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (6) · Stem Cells Arabia (6) · Goethe University (5) · University of Michigan Rogel Cancer Center (5) · General Hospital of Chinese Armed Police Forces (4) · Vinmec Research Institute of Stem Cell and Gene Technology (4)
United States (239) · Canada (15) · Iran (12) · Australia (11) · China (10) · Germany (10) · Puerto Rico (8) · France (5) · Italy (5) · Jordan (5) · New Zealand (5) · Saudi Arabia (4) · Vietnam (4) · Brazil (3) · Israel (3)
Hamid Gourabi, PhD (9) · Nasser Aghdami, MD,PhD (8) · Paul Orchard, MD (6) · Yago Nieto, MD, PHD (6) · Naoto Ueno, MD, PhD (5) · Partow Kebriaei, MD (5) · Gregory Hale, M.D. (4) · Dieter Hoelzer, MD,PhD (3) · Jeffrey Y Wong (3) · Margaret MacMillan, MD (3) · Neal Flomenberg, MD (3) · Phuong Vo (3) · Richard Burt, MD (3) · Richard E. Champlin, MD (3) · Uday R Popat (3)
PMID 19144982, PMID 21586746, PMID 22442346, PMID 22493293, PMID 27482888, PMID 27561722, PMID 28292947, PMID 28403842, PMID 28751559, PMID 33951890, PMID 34028986, PMID 38114596, PMID 42477805, PMID 12171484, PMID 18723429, PMID 19179301, PMID 19546405, PMID 19667400, PMID 19686048, PMID 20383216, PMID 20661232, PMID 20919852, PMID 21403127, PMID 21777972, PMID 21868572, PMID 21976674, PMID 21991976, PMID 22282904, PMID 22405058, PMID 22419704, PMID 22430088, PMID 22571201, PMID 22847303, PMID 23024237, PMID 23364976, PMID 23912587, PMID 24508444, PMID 25046834, PMID 25209445, PMID 25406723, PMID 25593079, PMID 25824692, PMID 26058927, PMID 26123356, PMID 26199392, PMID 26416896, PMID 26869630, PMID 27118452, PMID 27118571, PMID 27293053
P30CA033572 (15), U10CA180886 (12), P30CA016672 (7), U10CA098543 (6), U10CA180821 (6), U10CA180820 (5), U10CA031946 (3), U10CA180888 (3), U24CA076518 (3), P01HL075462 (2), P30CA015704 (2), P30CA138292 (2), U10CA032102 (2), 2009 (1), 2017 (1)